Search a ticker

Categories
Featured Investing Stock Market Today Stocks to Watch

Best Stocks To Buy Today? 3 Top Dividend Stocks To Watch

Top dividend stocks to watch this week.

best dividend stocks to buy now top dividend stocks

Dividend stocks are shares of companies that pay regular dividends to their shareholders as a way to provide them with a return on their investment. These dividends are a portion of the company’s profits that are distributed to investors. Dividend stocks are generally seen as a stable and reliable source of income, especially for investors seeking passive income or those nearing retirement.

The performance of dividend stocks is closely linked to the overall health of the economy. This comes as companies that can generate consistent profits are typically in a better situation to pay regular dividends. Additionally, during market corrections or economic slowdowns, dividend stocks may become even more attractive to investors as they offer a reliable income stream and a safer investment option.

Investing in dividend stocks requires an in-depth understanding of the company’s financials, dividend history, and potential for future growth. You should evaluate factors such as earnings, cash flow, and payout ratios before investing. Moreover, diversification is critical as investing solely in dividend stocks can be risky due to potential market volatility and changes in economic conditions. With that in mind, let’s dive into three dividend stocks to check out in the stock market this week.

Dividend Stocks To Watch Today

AbbVie (ABBV Stock)

To start, AbbVie Inc. (ABBV) is a biopharmaceutical company that specializes in research and development of drugs for the treatment of various diseases. The company is known for its leading position in the global market for Humira, a drug used to treat autoimmune diseases. AbbVie also has a diversified portfolio of other drugs in its pipeline, with a focus on oncology, immunology, and neuroscience. Currently, ABBV offers its shareholders an annual dividend yield of 3.73%.

Just last week, AbbVie announced its topline results from a Phase 2 study of upadacitinib (RINVOQ®), a drug used to treat autoimmune diseases, in combination with elsubrutinib, a Bruton’s Tyrosine Kinase inhibitor, for patients with systemic lupus erythematosus (SLE). The study met the primary endpoint of SLE Responder Index (SRI-4) and showed a steroid dose reduction in patients taking upadacitinib alone. Based on these results, AbbVie is planning to move forward with a Phase 3 clinical trial for upadacitinib in SLE.

Year-to-date, shares of ABBV stock have fallen by 2.41%. Though, during Tuesday morning’s trading session, ABBV stock is trading slightly higher off the open by 0.60% at $158.43 a share.

Source: TD Ameritrade TOS

[Read More] 3 Cyclical Stocks To Watch For March 2023

Altria Group (MO Stock)

Next, Altria Group Inc. (MO) is a tobacco company that produces and sells cigarettes, cigars, and other tobacco products. The company’s brands include Marlboro, Black & Mild, and Skoal. Altria Group is known for its strong market position. Today, MO has an annual dividend yield of 8.42%.

Also last week, Altria Group hosted its investor day conference in New York City. During the conference, Altria CEO Billy Gifford and other senior management members presented their 2028 Enterprise Goals, which include corporate financial metrics, specific US smoke-free volume and revenue targets, and aspirations to compete beyond the US nicotine space. The company also provided updates on internal product development efforts for smoke-free products. Additionally, the company reaffirmed its guidance to deliver 2023 full-year adjusted diluted EPS in a range of $4.98 to $5.13 and set a goal to deliver mid-single digits adjusted diluted EPS growth on a compounded annual basis through 2028.

So far in 2023, shares of MO stock have fallen by 2.04% year-to-date. Meanwhile, during Tuesday’s mid-morning trading action, MO stock opened higher by 0.61% at $44.58 a share.

Source: TD Ameritrade TOS

[Read More] Best Bank Stocks To Buy Now? 3 For Your Watchlist

International Business Machines (IBM Stock)

Lastly, International Business Machines Corporation (IBM) is a multinational technology company that provides hardware, software, and services to clients in various industries. The company has extensive expertise in cloud computing, artificial intelligence, and cybersecurity. Moreover, currently, IBM offers its stockholders an annual dividend yield of 5.09%.

Back in January, IBM reported its Q4 2022 financial results. In detail, the company showed earnings of $3.60 per share with revenue of $16.7 billion. This is in comparison to analysts’ consensus estimates for the quarter which was an EPS of $3.61, on revenue of $16.4 billion.

In 2023 thus far, IBM stock has fallen by 8.54% YTD. Though, on Tuesday morning, shares of IBM stock are trading modestly higher off the open by 0.10% at $129.44 a share.

Source: TD Ameritrade TOS

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

By Jonathan Phillip

Jonathan Phillip is an up and coming financial contributor in the stock market today. He's found a strong niche in writing about true growth industries. His main focus for the last 5 years has been on the cannabis industry and marijuana stocks. He is one of the top contributors to cannabis media outlets like MarijuanaStocks.com. He also is head of social media management for StockMarket.com.

Since an early age, Jonathan has been an active member of the cannabis culture. Coming from Miami, Florida, he's been able to identify emerging trends in the space including the emergence of cannabis derivatives, vapes, e-liquids, wax, and more. His ability to identify emerging niches has afforded him the ability to source valuable information from top industry names.

Jonathan has also managed to build a strong social media presence for companies. He has worked with hundreds of public companies to develop a digital presence. As an active blogger and social media influencer, his focus is on lifestyle segments of the market. You can find Jonathan reporting on anything from industry conferences and investor events to corporate disclosures and cannabis market movers.

Since the early days of marijuana companies going public, Jonathan has made it a point to find information before the crowd. The main target of his writing is on undiscovered or under-researched companies that could hold true, lasting market potential. Through his research, Jonathan has managed to be one of the early writers to identify the opportunity of cannabis over other things like alcohol and he was one of the first reporters to cover the multi-billion dollar deals that materialized in 2017 and 2018. He has also covered the emergence of multi-state operators in the U.S. after Canada paved the way in late 2018 and 2019 for legalization in North America.

Jonathan is also an active member of the underground hip-hop scene. He has worked with some of the biggest names in the rap community while also gaining valuable insight from top producers and business moguls focused on moving brands forward. In his free time, Jonathan builds social communities and continues to hone his skills as a leading financial writer.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments